Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor‐induced disseminated intravascular coagulation in rats
- 1 April 1994
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 45 (4) , 298-303
- https://doi.org/10.1002/ajh.2830450406
Abstract
This study demonstrated that intravenous infusion of recombinant human soluble thrombomodulin (rhs‐TM) could Inhibit disseminated Intravascuiar coagulation (DIC) caused by 4 hr infusion of tissue factor (TF) in rats. Extended infusion of TF reduced fibrinogen and platelet counts and elevated serum FDP level. Pretreatment and coinfusion of rhs‐TM could block changes of these DIC‐parameters without prolongation of APTT. Heparin, which is a potent anti‐DIC drug, could also inhibit these changes with extra prolongation of APTT and PT. Thus, these results suggest thrombomodulin prevent DIC less bleeding tendency than heparin.Keywords
This publication has 23 references indexed in Scilit:
- Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in ratsThrombosis Research, 1993
- Recombinant Human Soluble Thrombomodulin Delivers Bounded Thrombin to Antithrombin III: Thrombomodulin Associates with Free Thrombin and Is Recycled to Activate Protein CThrombosis and Haemostasis, 1993
- Intravenous recombinant soluble human thrombomodulin prevents venous thrombosis in a rat modelJournal of Vascular Surgery, 1991
- Aspartic acid 349 in the fourth epidermal growth factor-like structure of human thrombomodulin plays a role in its Ca(2+)-mediated binding to protein C.Journal of Biological Chemistry, 1991
- Presence and function of chondroitin-4-sulfate on recombinant human soluble thrombomodulinBiochemical and Biophysical Research Communications, 1990
- Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells.Journal of Biological Chemistry, 1990
- The Last Three Consecutive Epidermal Growth Factor-like Structures of Human Thrombomodulin Comprise the Minimum Functional Domain for Protein C-activating Cofactor Activity and Anticoagulant ActivityJournal of Biological Chemistry, 1989
- ThrombomodulinSeminars in Thrombosis and Hemostasis, 1987
- Heparin and the Activated Partial Thromboplastin Time — A Difference between theIn-vitroandIn-vivoEffects and Implications for the Therapeutic RangeAmerican Journal of Clinical Pathology, 1980
- Antithrombotic DrugsDrugs, 1976